Clinical Trials in Minneapolis

Showing 5961-5980 of 14,456 trials

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

NCT00984113

The purpose of the study is to determine the pharmacokinetics and safety of elinogrel and its metabolite in patients with mild, moderate, and severe renal impairment compared to healthy volunteers.

Renal Impairment

Portola Pharmaceuticals44 participantsStarted Sep 2009

Minneapolis, Minnesota, United States • Knoxville, Tennessee, United States

COMPLETEDPhase 18.7 miles

A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants

NCT05976360

This is a phase 1, single subcutaneous dose study to evaluate safety and pharmacokinetics of 2 different dupilumab drug product in healthy volunteers. The duration per participant is up to 11 weeks.

Healthy Volunteer

Sanofi38 participantsStarted Nov 2014

Saint Paul, Minnesota, United States • Springfield, Missouri, United States

COMPLETEDNA302 miles

Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT00346320

RATIONALE: Radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well radiation therapy works in treating patients with stage I or stage II non-small cell lung cancer that cannot be removed by surgery.

Lung Cancer

NCIC Clinical Trials Group80 participantsStarted Aug 2006

Calgary, Alberta, Canada • Kelowna, British Columbia, Canada • Surrey, British Columbia, Canada +16 more locations

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants

Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Find Trials by Condition in Minneapolis

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Bortezomib in Treating Patients With Mantle Cell Lymphoma

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Early Powered Mobility for Toddlers With Cerebral Palsy Using the Permobil® Explorer Mini and a Modified Ride-On Car

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma

Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy

A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

A Phase I Study of CX5461

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma